TY - JOUR
T1 - Lymphadenopathy in Asymptomatic Patients Seropositive for HIV
AU - Osmond, Dennis
AU - Chaisson, Richard
AU - Moss, Andrew
AU - Bacchetti, Peter
AU - Krampf, Walter
PY - 1987/7/23
Y1 - 1987/7/23
N2 - To the Editor: The Public Health Service has called for “a system for classifying HTLV-III/LAV [HIV] associated disease manifestations which is useful in the design, implementation, and analyses of therapeutic trials.”1 The Centers for Disease Control system,2 intended for broad application to public health activities, divides HIV manifestations into four groups: acute infection, asymptomatic infection, persistent generalized lymphadenopathy, and other manifestations. The assumption that the groups are hierarchically arranged according to the severity of disease appears to be widespread. This has resulted in the use of persistent generalized lymphadenopathy to distinguish groups of HIV-seropositive subjects in prospective studies and to…
AB - To the Editor: The Public Health Service has called for “a system for classifying HTLV-III/LAV [HIV] associated disease manifestations which is useful in the design, implementation, and analyses of therapeutic trials.”1 The Centers for Disease Control system,2 intended for broad application to public health activities, divides HIV manifestations into four groups: acute infection, asymptomatic infection, persistent generalized lymphadenopathy, and other manifestations. The assumption that the groups are hierarchically arranged according to the severity of disease appears to be widespread. This has resulted in the use of persistent generalized lymphadenopathy to distinguish groups of HIV-seropositive subjects in prospective studies and to…
UR - http://www.scopus.com/inward/record.url?scp=0023255989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023255989&partnerID=8YFLogxK
U2 - 10.1056/NEJM198707233170413
DO - 10.1056/NEJM198707233170413
M3 - Letter
C2 - 3474522
AN - SCOPUS:0023255989
SN - 0028-4793
VL - 317
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 4
ER -